GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Shiller PE Ratio

Hamlet BioPharma AB publ (XSAT:HAMLET B) Shiller PE Ratio : (As of Jul. 24, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hamlet BioPharma AB publ Shiller PE Ratio Historical Data

The historical data trend for Hamlet BioPharma AB publ's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Shiller PE Ratio Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hamlet BioPharma AB publ's Shiller PE Ratio

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Shiller PE Ratio falls into.


;
;

Hamlet BioPharma AB publ Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hamlet BioPharma AB publ's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Hamlet BioPharma AB publ's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.07/132.8245*132.8245
=-0.070

Current CPI (Mar. 2025) = 132.8245.

Hamlet BioPharma AB publ Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -0.003 99.995 -0.004
201509 -0.009 100.228 -0.012
201512 -0.022 100.276 -0.029
201603 -0.012 100.751 -0.016
201606 -0.023 101.019 -0.030
201609 -0.014 101.138 -0.018
201612 -0.030 102.022 -0.039
201703 -0.072 102.022 -0.094
201706 -0.026 102.752 -0.034
201709 -0.042 103.279 -0.054
201712 -0.036 103.793 -0.046
201803 -0.055 103.962 -0.070
201806 -0.035 104.875 -0.044
201809 -0.031 105.679 -0.039
201812 -0.034 105.912 -0.043
201903 -0.041 105.886 -0.051
201906 -0.067 106.742 -0.083
201909 -0.027 107.214 -0.033
201912 -0.077 107.766 -0.095
202003 -0.059 106.563 -0.074
202006 -0.061 107.498 -0.075
202009 -0.018 107.635 -0.022
202012 -0.027 108.296 -0.033
202103 -0.022 108.360 -0.027
202106 -0.007 108.928 -0.009
202109 -0.018 110.338 -0.022
202112 -0.026 112.486 -0.031
202203 -0.038 114.825 -0.044
202206 -0.068 118.384 -0.076
202209 -0.049 122.296 -0.053
202212 -0.054 126.365 -0.057
202303 -0.050 127.042 -0.052
202306 -0.027 129.407 -0.028
202309 -0.070 130.224 -0.071
202312 -0.073 131.912 -0.074
202403 -0.098 132.205 -0.098
202406 -0.069 132.716 -0.069
202409 -0.061 132.304 -0.061
202412 -0.081 132.987 -0.081
202503 -0.070 132.825 -0.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hamlet BioPharma AB publ Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines